Hiroyuki Imaki

1.7k total citations · 1 hit paper
9 papers, 1.4k citations indexed

About

Hiroyuki Imaki is a scholar working on Molecular Biology, Oncology and Ophthalmology. According to data from OpenAlex, Hiroyuki Imaki has authored 9 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Ophthalmology. Recurrent topics in Hiroyuki Imaki's work include Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (2 papers) and Glaucoma and retinal disorders (2 papers). Hiroyuki Imaki is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (2 papers) and Glaucoma and retinal disorders (2 papers). Hiroyuki Imaki collaborates with scholars based in Japan and United States. Hiroyuki Imaki's co-authors include Keiichi I. Nakayama, Keiko Nakayama, Shigetsugu Hatakeyama, Takumi Kamura, Masayoshi Yada, N. Ishida, Ryosuke Tsunematsu, Fumihiko Okumura, Masaaki Nishiyama and Masaaki Abe and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The EMBO Journal.

In The Last Decade

Hiroyuki Imaki

8 papers receiving 1.4k citations

Hit Papers

Phosphorylation‐dependent degradation of c‐Myc is mediate... 2004 2026 2011 2018 2004 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyuki Imaki Japan 8 1.1k 510 220 207 155 9 1.4k
Michelle B. Crosby United States 10 777 0.7× 516 1.0× 178 0.8× 302 1.5× 171 1.1× 12 1.4k
Chiara Luise Italy 13 1.5k 1.3× 669 1.3× 268 1.2× 188 0.9× 312 2.0× 16 1.9k
Kiran Mahajan United States 24 1.5k 1.3× 495 1.0× 197 0.9× 191 0.9× 273 1.8× 38 1.9k
Yoon Jong Choi United States 11 1.3k 1.1× 813 1.6× 286 1.3× 145 0.7× 240 1.5× 19 1.9k
Charles R. Holst United States 12 840 0.7× 423 0.8× 171 0.8× 188 0.9× 235 1.5× 14 1.4k
Andrea Kauffmann-Zeh United Kingdom 7 1.2k 1.1× 342 0.7× 268 1.2× 160 0.8× 203 1.3× 10 1.5k
Micaela Quarto Italy 16 1.5k 1.4× 773 1.5× 159 0.7× 204 1.0× 318 2.1× 18 1.9k
Alessandro Verrecchia Italy 17 1.1k 0.9× 446 0.9× 163 0.7× 316 1.5× 184 1.2× 23 1.4k
Danielle K. Lynch Australia 8 815 0.7× 388 0.8× 321 1.5× 149 0.7× 143 0.9× 8 1.2k
Kimita Suyama United States 11 933 0.8× 445 0.9× 276 1.3× 84 0.4× 214 1.4× 18 1.3k

Countries citing papers authored by Hiroyuki Imaki

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Imaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Imaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Imaki more than expected).

Fields of papers citing papers by Hiroyuki Imaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Imaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Imaki. The network helps show where Hiroyuki Imaki may publish in the future.

Co-authorship network of co-authors of Hiroyuki Imaki

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Imaki. A scholar is included among the top collaborators of Hiroyuki Imaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Imaki. Hiroyuki Imaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Imaki, Hiroyuki, et al.. (2015). A Japanese case of neuroborreliosis with papillitis. Rinsho Shinkeigaku. 55(4). 248–253.
2.
Yamashita, Toshifumi, Taiji Sakamoto, Takehiro Yamashita, et al.. (2014). INDIVIDUALIZED, SPECTRAL DOMAIN-OPTICAL COHERENCE TOMOGRAPHY–GUIDED FACEDOWN POSTURING AFTER MACULAR HOLE SURGERY. Retina. 34(7). 1367–1375. 24 indexed citations
3.
Yoshida, Noriko, Toshio Hisatomi, Yasuhiro Ikeda, et al.. (2011). Intravitreal bevacizumab treatment for neovascular glaucoma: histopathological analysis of trabeculectomy specimens. Graefe s Archive for Clinical and Experimental Ophthalmology. 249(10). 1547–1552. 13 indexed citations
4.
Yada, Masayoshi, Shigetsugu Hatakeyama, Takumi Kamura, et al.. (2004). Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7. The EMBO Journal. 23(10). 2116–2125. 660 indexed citations breakdown →
5.
Kamura, Takumi, Taichi Hara, Shuhei Kotoshiba, et al.. (2003). Degradation of p57 Kip2 mediated by SCF Skp2 -dependent ubiquitylation. Proceedings of the National Academy of Sciences. 100(18). 10231–10236. 250 indexed citations
6.
Imaki, Hiroyuki, Keiko Nakayama, Hiroshi Handa, et al.. (2003). Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein.. PubMed. 63(15). 4607–13. 76 indexed citations
7.
Yamanaka, Atsushi, Masayoshi Yada, Hiroyuki Imaki, et al.. (2002). Multiple Skp1-Related Proteins in Caenorhabditis elegans. Current Biology. 12(4). 267–275. 63 indexed citations
8.
Miyamoto, Akitomo, Keiko Nakayama, Hiroyuki Imaki, et al.. (2002). Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cδ. Nature. 416(6883). 865–869. 336 indexed citations
9.
Nakao, A., Tsuyoshi Watanabe, Haruhiko Bito, et al.. (1997). cAMP mediates homologous downregulation of PAF receptor mRNA expression in mesangial cells. American Journal of Physiology-Renal Physiology. 273(3). F445–F450. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026